 |
|
|
|
 |
egories |
 |
 |
New Addition |
 |
|
|
 |
Details: |
 |
|
|
Early stage pharmaceutical company specializing in targeted delivery of therapeutic componds to specific immune cells as cost-effective therapy for inflammatory & autoimmune diseases.
|
| URL: |
|
| Title: |
|
| Description: |
Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Research and Development - SERAF Therapeutics, Inc.. Early stage pharmaceutical company specializing in targeted delivery of therapeutic componds to specific immune cells as cost-effective therapy for inflammatory & |
| Specialized in: |
|
|
 |
|
 |
AlteonPharma (Popularity: ): Development of pharmaceutical products for the complications of diabetes and age-related diseases.
Chiroscience (Popularity: ): Chiroscience Group plc is an emerging pharmaceutical company which uses its diverse technology platform to discover and develop novel medicines ...
MDL Information Systems, Inc. (Popularity: ): MDL is a leading provider of integrated logistics and decision support systems that enable a high-throughput environment for research and ...
Key Oncologics (Pty) Ltd, South Africa (Popularity: ): Biopharmaceutical company with a focus on marketing anticancer pharmaceuticals, and conducting oncology clinical trials.
Pharmadigm, Inc. (Popularity: ): Pharmadigm is developing a new class of anti-inflammatory agent useful in the management of acute inflammatory responses associated with burns, ...
Tuberculosis Research Centre (Popularity: ): Established in 1956 under the auspices of the Indian Council of Medical Research, the World Health Organisation and the British ...
Karo Bio AB (Popularity: ): A drug discovery company focusing its research on the discovery and pre-clinical phases of drug development.
Mercodia (Popularity: ): Specialising in the research, development, and manufacture of quality in vitro diagnostics products.
Pherin Pharmaceutical (Popularity: ): Pherin Pharmaceuticals is focused on the discovery and development of vomeropherins, a new family of pharmaceutical compounds for the treatment ...
Integrated Biologics Research Laboratories (Popularity: ): The use of zwitterionic technology to treat disease. Research and development of new therapeutic modalities for cancer, immunology and infectious ...
|
 |
Popular Sites |
 |
AlteonPharma (Popularity: ): Development of pharmaceutical products for the complications of diabetes and age-related diseases.
Mercodia (Popularity: ): Specialising in the research, development, and manufacture of quality in vitro diagnostics products.
Chiroscience (Popularity: ): Chiroscience Group plc is an emerging pharmaceutical company which uses its diverse technology platform to discover and develop novel medicines ...
ProCertus BioPharm, Inc. (Popularity: ): Developing products that: 1) Protect humans against the debilitating side effects of cancer chemotherapy and radiotherapy, and 2) Protect animals ...
Karo Bio AB (Popularity: ): A drug discovery company focusing its research on the discovery and pre-clinical phases of drug development.
|
 |
Related Press |
 |
Kiadis Pharma Announces ATIR Interim Clinical Results (Popularity: ): Kiadis Pharma today announced interim results of a physician initiated European Phase II clinical study for its lead product ATIR. ...
GlaxoSmithKline and Cellzome Announce Major Strategic Alliance (Popularity: ): Cellzome Inc. and GlaxoSmithKline (LSE & NYSE: GSK) announce the signing of a worldwide strategic alliance to discover, develop and ...
Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules (Popularity: ): Quark Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel RNA interference-based therapeutics, announced today that the ...
Robert W. Lee, Ph.D. Joins Particle Sciences as Vice President of Pharmaceutical Development (Popularity: ): Particle Sciences, Inc. today announced the appointment of Robert W. Lee, Ph.D. to the position of Vice President, Pharmaceutical Development. ...
Lentigen Corporation Announces Exclusive Licensing Agreement With Case Western Reserve University to Develop Novel Stem-Cell Therapy for Brain Cancer (Popularity: ): Lentigen Corporation today announced an exclusive licensing agreement with Case Western Reserve University (CWRU) in Cleveland, Ohio, to develop a ...
|
 |
Related Articles |
 |
|
|
 |
|
 |
| |
| | |
|
|
|
© 2003-2008, ABC-Directory.Com. All Rights Reserved
|
|
|
 |
|
 |
|